Taiwan's Advisory Committee on Immunization Practices (ACIP) on Monday approved the use of Moderna's second-generation COVID-19 vaccine as a booster shot for recipients at high risk of infection or severe disease.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taipower plans 43 substations over next 15 years as power demand grows
10/14/2026 05:46 PM - Business
U.S. dollar closes lower on Taipei forex market
10/14/2026 04:16 PM - Business
Taiwan shares rise as TSMC retreat limits gains
10/14/2026 04:10 PM - Culture
Taiwan agency, Korean producer agree to cooperate on film, TV development
10/14/2026 04:05 PM - Society
1,336 people officially recognized as Siraya since July: CIP
10/14/2026 04:04 PM